Recently, we found that IGFBP-3 binds HA through residues 215–232 in the C-terminal region of the protein (215-KKGFYKKKQCRPSKGRKR-232) and blocks its interactions with CD44, reducing cell viability of A549 human lung cancer cells51. The gene discussed is CD44; the disease is lung cancer.